3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Neoplasms
1522
Carcinoma, Non-Small-Cell Lung
758
Breast Neoplasms
572
Neoplasm Metastasis
531
Colorectal Neoplasms
448
Melanoma
391
Leukemia, Myeloid, Acute
372
Multiple Myeloma
364
Ovarian Neoplasms
354
Recurrence
336
Lymphoma
334
Advanced Solid Tumors
325
Lymphoma, Non-Hodgkin
315
Prostatic Neoplasms
300
Pancreatic Neoplasms
285
Advanced Solid Tumor
240
Stomach Neoplasms
233
Carcinoma, Renal Cell
226
Squamous Cell Carcinoma of Head and Neck
211
Lung Neoplasms
210
Solid Tumor
204
Leukemia, Lymphocytic, Chronic, B-Cell
198
Triple Negative Breast Neoplasms
185
Solid Tumors
183
Carcinoma, Hepatocellular
165
Hematologic Neoplasms
155
Head and Neck Neoplasms
153
Lymphoma, Large B-Cell, Diffuse
148
Lymphoma, Follicular
146
Glioblastoma
145
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
INDUSTRY
×
Solitary Fibrous Tumors
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled